Company news
Repligen Corporation news in 2020
Repligen Corporation's news releases, calls and decks from 2020, newest first.
Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including Full Exercise of Underwriters’ Option
December 9, 2020
Repligen Corporation Prices Public Offering of Shares of Common Stock
December 6, 2020
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
December 6, 2020
Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
November 4, 2020
Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
October 26, 2020
Repligen to Report Third Quarter 2020 Financial Results
October 21, 2020
Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines
September 30, 2020
Repligen Reports Second Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
July 29, 2020
Repligen to Report Second Quarter 2020 Financial Results
July 14, 2020
Repligen Announces Agreement to Acquire Engineered Molding Technology
June 28, 2020
Repligen Appoints Carrie Eglinton Manner to Board of Directors
June 14, 2020
Repligen Reports First Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
May 5, 2020
Repligen to Report First Quarter 2020 Financial Results
April 21, 2020
Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors
February 26, 2020
Repligen Reports Fourth Quarter and Full Year 2019 Financial Results
February 19, 2020
Repligen to Report Fourth Quarter and Full Year 2019 Financial Results
February 5, 2020
Repligen to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 6, 2020
Calls in 2020
Decks in 2020
- Merger or Acquisition (October 2020)
Merger or acquisition · 9 slides · Oct 27, 2020